In the BioHarmony Drug Report Database
Almotriptan
Axert (almotriptan) is a small molecule pharmaceutical. Almotriptan was first approved as Axert on 2001-05-07. It is used to treat migraine disorders in the USA. It is known to target 5-hydroxytryptamine receptor 1B and 5-hydroxytryptamine receptor 1D.
Trade Name
|
Axert |
|---|---|
Common Name
|
almotriptan |
ChEMBL ID
|
CHEMBL1505 |
Indication
|
migraine disorders |
Drug Class
|
Antimigraine agents (5-HT1 receptor agonists),sumatriptan derivatives |
Image (chem structure or protein)